Wall Street's October 20 session showed signs of investors favoring healthcare and value stocks over some AI-linked names. Eli Lilly, Moderna and several companies outside big technology outperformed as investors weighed earnings and the cost of AI infrastructure.
Investors are becoming more selective about artificial intelligence stocks as questions grow about valuations and the returns from heavy data-center spending. Tuesday's market action offered a glimpse of where some money is moving: healthcare and value stocks gained ground while several AI-linked shares struggled.
The Reuters market report showed the Dow Jones Industrial Average rising 1% to 52,485.50. The S&P 500 advanced 0.4% to 7,721.44, while the Nasdaq Composite added 0.2% to 26,482.94.
Healthcare led sector gains. Real estate and utilities also rose more than 1%, and the Russell 2000 small-cap index climbed 1.7%. The S&P 500 value index gained 0.8%, while its growth counterpart edged lower.
The pattern suggests investors were broadening their exposure beyond the biggest growth names. It does not prove a wholesale exit from AI, but it comes after a sharp technology selloff last week and renewed scrutiny of the cost of building AI infrastructure.
Healthcare and Value Stocks Draw Investor Interest
Eli Lilly (NYSE: LLY) and Moderna (NASDAQ: MRNA) were among the healthcare names highlighted in Reuters' account of Tuesday's gains. The sector's strength comes as investors consider companies with distinct earnings drivers outside the AI infrastructure trade.
Healthcare stocks do not all behave alike. Drugmakers depend on clinical results, regulatory decisions and sales growth, while medical technology and service companies face different pressures. Investors should assess each business individually rather than assume the whole sector will outperform.
The broader move toward value stocks also suggests that valuation is becoming a more important consideration. Value-oriented shares tend to trade at lower prices relative to measures such as earnings or book value than growth stocks, though those lower valuations do not guarantee better returns.
3M (NYSE: MMM) rose after expanding its commercial relationship with Amazon. The industrial company also issued an Amazon subsidiary a warrant that gives it the right to buy 3M common stock worth more than $521 million. The announcement added a company-specific catalyst to the day's broader rotation.
Equifax (NYSE: EFX) and Hasbro (NASDAQ: HAS) each gained about 10% after reporting results that beat expectations or improving their forecasts. Their moves illustrate how earnings news can drive individual stocks even when broader market sentiment is unsettled.
Investors looking for context on the wider shift can read Wealthier Today's analysis of semiconductor stocks losing ground in October. The report examines how higher financing costs and questions about AI infrastructure returns have weighed on chipmakers.
Why Investors Are Reconsidering the AI Trade
The rotation follows concerns about the amount of capital required to build AI infrastructure and whether that spending will generate sufficient returns. CoreWeave (NASDAQ: CRWV), an AI cloud infrastructure provider, and Nebius Group (NASDAQ: NBIS) were among the stocks that fell in premarket trading on Tuesday. Apple (NASDAQ: AAPL) also declined, while Nvidia (NASDAQ: NVDA) slipped marginally.
Those moves came after a brief rebound on Monday, when investors bought technology shares following last week's selloff. The changing direction highlights how sensitive AI-linked stocks have become to concerns about debt, financing costs and the outlook for future spending.
The market is not necessarily rejecting AI's long-term potential. Rather, investors appear to be scrutinizing which companies can turn heavy investment into sustainable revenue and profit. That distinction matters because a company can benefit from growing demand for AI while still face pressure if its valuation assumes exceptionally strong future growth.
The next test will come from corporate earnings. Netflix and SpaceX were scheduled to report after Tuesday's market close, while Meta Platforms (NASDAQ: META) and Tesla (NASDAQ: TSLA) were due to report Wednesday. Their results and outlooks could shape sentiment toward technology and the wider market.
Investors can follow Wealthier Today's coverage of stocks driving Wall Street's recent rally and its broader investing news to track whether market leadership continues to spread beyond the largest technology companies.
For now, the evidence points to selective repositioning rather than a clear-cut exodus from AI. Healthcare and value shares are attracting attention, but the sustainability of the shift will depend on earnings, valuations and whether AI-related companies can demonstrate that their spending is producing meaningful returns.